Skip to main content
$1.63 $0.01 (0.6%)

04:30 PM EDT on 08/13/20

Strata Skin Sciences Inc Com (NASDAQ:SSKN)

CAPS Rating: No stars

A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.

Current Price $1.63 Mkt Cap $56.0M
Open $1.79 P/E Ratio 0.00
Prev. Close $1.63 Div. (Yield) $0.00 (0.0%)
Daily Range $1.56 - $1.80 Volume 738,772
52-Wk Range $0.75 - $2.84 Avg. Daily Vol. 92,565

Caps

How do you think NASDAQ:SSKN will perform against the market?

Add Stock to CAPS Watchlist

All Players

196 Outperform
33 Underperform
 

All-Star Players

16 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SSKN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

FWWright (26.48)
Submitted June 15, 2012

I have had skin cancer and will have more and am waiting for my dermatologist to buy a non-invasive tester so he doesn't just freeze everything off or in the worse looking ones have me make a separate appointment for removal/biopsy.

markofzorro (42.20)
Submitted May 19, 2010

Based on MELA's press release, it is unclear if MelaFind will find new cases of melanoma that dermatologists don't already suspect. MELA's study was done in people the dermatologists already suspected melanoma, not the general public. It is not a… More

Recent Community Commentary

Read the most recent pitches from players about SSKN.

Recs

0
Member Avatar DarthJon (< 20) Submitted: 8/1/2019 10:04:23 AM : Outperform Start Price: $2.85 NASDAQ:SSKN Score: -55.42

Medical technology in the dermatology field. Good revenue/income growth and positive cash flow.

Recs

2
Member Avatar FWWright (26.48) Submitted: 6/14/2012 11:18:56 PM : Outperform Start Price: $127.50 NASDAQ:SSKN Score: -250.77

I have had skin cancer and will have more and am waiting for my dermatologist to buy a non-invasive tester so he doesn't just freeze everything off or in the worse looking ones have me make a separate appointment for removal/biopsy.

Recs

0
Member Avatar WRXkid (81.56) Submitted: 3/29/2012 2:01:49 PM : Outperform Start Price: $215.50 NASDAQ:SSKN Score: -240.28

Commercial launch of MelaFind in EU and US.

Leaderboard

Find the members with the highest scoring picks in SSKN.

Score Leader

anticitradeshort

anticitradeshort (29.20) Score: +396.60

The Score Leader is the player with the highest score across all their picks in SSKN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 29.20 4/20/2009 Underperform NS $327.00 -99.50% +297.10% +396.60 0 Comment
wackydaddy < 20 5/4/2009 4/25/2010 Underperform 3Y $425.00 -99.62% +283.62% +383.23 1 Comment
ModernDayWarrior 37.78 10/27/2009 Underperform 5Y $564.00 -99.71% +214.10% +313.81 0 Comment
NobullWalrus < 20 10/27/2009 Underperform 1Y $564.00 -99.71% +214.10% +313.81 1 Comment
39272x6 98.80 11/13/2009 Underperform 5Y $415.00 -99.61% +207.55% +307.15 0 Comment
drugncover 50.16 9/10/2010 Underperform 1Y $337.00 -99.52% +201.61% +301.13 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. markofzorro 42.20 5/19/2010 Underperform 5Y $295.50 -99.45% +201.18% +300.63 10 Comments
jroren 99.11 6/21/2010 Underperform 3M $440.50 -99.63% +197.19% +296.82 0 Comment
Jaspers0Debt 56.74 11/17/2010 Underperform 5Y $132.50 -98.77% +183.89% +282.66 0 Comment
fastred55 < 20 11/23/2010 Underperform 5Y $212.50 -99.23% +183.05% +282.28 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SSKN.